Previous 10 | Next 10 |
Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...
2024-02-14 17:35:58 ET Major earnings expected after the bell on Thursday include: Roku ( ROKU ) Coinbase Global ( COIN ) Applied Materials ( AMAT ) The Trade Desk ( TTD ) DraftKings ( DKNG ) Read the full article on Seeking Alpha For ...
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results PR Newswire ATLANTA , Feb. 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on a...
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting PR Newswire Full IDE Data Set Demonstrates Statistically Significant Reduction of All-Cause Mortality and Primary Major Adverse Events (MAEs) ...
Artivion Obtains $350 Million in Senior Secured Credit Facilities PR Newswire Non-Dilutive Financing Provides Comprehensive Solution to Address Debt Maturities and Provide Flexibility to Further Optimize Capital Structure ATLANTA , Jan. 18, 2024...
2023-12-27 11:37:05 ET Summary Today we look at small medical device maker Artivion, Inc., which has seen a roller coaster ride in its stock over the past year. The company manufactures and distributes medical devices such as aortic stents and implantable human tissues. Manage...
2023-12-07 06:31:55 ET More on Artivion Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025 Artivion Non-GAAP EPS of $0.02 misses by $0.01, revenue of $87.9M beats by $3.58M Seeking Alpha’s Quant Rating on Artivion For f...
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer PR Newswire Reaffirms Financial Guidance Provided on November 2, 2023 ATLANTA , Dec. 6, 2023 /PRNewsw...
2023-11-21 19:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Artivion Announces Completion of Enrollment in PERSEVERE Trial PR Newswire ATLANTA , Nov. 9, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it has completed enro...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 11:00:15 ET Frank Takkinen from Lake Street issued a price target of $30.00 for AORT on 2024-07-10 09:08:00. The adjusted price target was set to $30.00. At the time of the announcement, AORT was trading at $25.94. The overall price target consensus is at $30....
2024-07-02 12:00:05 ET Frank Takkinen from Loop Capital Markets issued a price target of $30.00 for AORT on 2024-07-02 08:49:00. The adjusted price target was set to $30.00. At the time of the announcement, AORT was trading at $26.015. The overall price target consensus ...